Reatix Tablet (6’s) is a combination medication designed for the treatment of HIV-1 infection, providing a comprehensive approach to antiretroviral therapy. Each tablet contains Tenofovir disoproxil fumarate (300mg), Emtricitabine (200mg), Atazanavir (300mg), and Ritonavir (100mg), which work synergistically to inhibit the replication of the virus. Tenofovir and Emtricitabine are nucleoside reverse transcriptase inhibitors (NRTIs) that block the reverse transcription process, while Atazanavir, a protease inhibitor, prevents viral maturation. Ritonavir enhances the effectiveness of Atazanavir by inhibiting its metabolism, allowing for lower doses and improved efficacy. This combination not only helps in managing HIV but also aids in reducing the risk of HIV transmission. Reatix Tablet is typically prescribed as part of a comprehensive treatment plan, which may include other medications and lifestyle modifications to ensure optimal health outcomes for individuals living with HIV.